NCT03635411View on ClinicalTrials.gov

Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET)

PHASE1UnknownINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2020

Conditions
Recovery of Function
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside and Pterostilbene

Nicotinamide riboside and pterostilbene manufactured by Basis

DIETARY_SUPPLEMENT

Placebo

Sugar pill manufactured to mimic Basis supplement.

Trial Locations (1)

19104

RECRUITING

Penn Presbyterian Medical Center, Philadelphia

Sponsors

Lead Sponsor

Elysium Health
All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

Elysium Health

INDUSTRY

NCT03635411 - Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET) | Biotech Hunter | Biotech Hunter